ADRB2 Arg16 and the need for collaboration in childhood asthma pharmacogenomics

Author： Vijverberg Susanne JH   Raaijmakers Jan AM   Maitland-van der Zee Anke Hilse  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.14, Iss.16, 2013-12, pp. : 1937-1939

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Arg16 ADRB2 genotype increases the risk of asthma exacerbation in children with a reported use of long-acting &bgr;2-agonists: results of the pacman cohort

By Zuurhout Miranda JL   Vijverberg Susanne JH   Raaijmakers Jan AM   Koenderman Leo   Postma Dirkje S   Koppelman Gerard H   Maitland-van der Zee Anke Hilse  

Pharmacogenomics, Vol. 14, Iss. 16, 2013-12 ,pp. : 1965-1971

Future Medicine

Access to resources Recommend Favorite

Pharmacogenomics of Asthma

By  

Current Pharmaceutical Design, Vol. 12, Iss. 25, 2006-09 ,pp. : 3195-3206

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenomics of cytarabine in childhood leukemia

By Lamba Jatinder K  

Pharmacogenomics, Vol. 12, Iss. 12, 2011-12 ,pp. : 1629-1632

Future Medicine

Access to resources Recommend Favorite

Role and Pharmacogenomics of TNF- in Asthma

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 9, 2008-08 ,pp. : 934-942

Bentham Science Publishers

Access to resources Recommend Favorite

Carvedilol pharmacokinetics and pharmacodynamics in relation to CYP2D6 and ADRB pharmacogenetics

By Sehrt Daniel   Meineke Ingolf   Tzvetkov Mladen   Güültepe Senol   Brockmööller Jüürgen  

Pharmacogenomics, Vol. 12, Iss. 6, 2011-06 ,pp. : 783-795

Future Medicine

Access to resources Recommend Favorite